Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 42,000 shares of the company’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $1.74, for a total value of $73,080.00. Following the completion of the sale, the chairman now owns 1,453,543 shares […]
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 789,000 shares, a growth of 6.1% from the November 15th total of 743,700 shares. Currently, 4.6% of the company’s stock are sold short. Based on an […]